Maximizing neuroprotection: where do we stand?

被引:11
|
作者
Kuffler, Damien P. [1 ]
机构
[1] Univ Puerto Rico, Inst Neurobiol, San Juan, PR 00901 USA
来源
THERAPEUTICS AND CLINICAL RISK MANAGEMENT | 2012年 / 8卷
关键词
adenosine; hypothermia; alkalinization; glucocorticoids; SPINAL-CORD-INJURY; RETROGRADE VENOUS PERFUSION; ADENOSINE A(2A) AGONIST; CULTURED HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; RAT SENSORY NEURONS; CELL-DEATH; IN-VITRO; GLUTAMATE NEUROTOXICITY; CEREBRAL-ISCHEMIA;
D O I
10.2147/TCRM.S16196
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Brain and spinal cord traumas include blunt and penetrating trauma, disease, and required surgery. Such traumas trigger events such as inflammation, infiltration of inflammatory and other cells, oxidative stress, acidification, excitotoxicity, ischemia, and the loss of calcium homeostasis, all of which cause neurotoxicity and neuron death. To prevent trauma-induced neurological deficits and death, each of the many neurotoxic events that occur in parallel or sequentially must be minimized or prevented. Although neuroprotective techniques have been developed that block single neurotoxic events, most provide only limited neuroprotection and are only applied singly. However, because many neurotoxicity triggers arise from common events, an approach for invoking more effective neuroprotection is to apply multiple neuroprotective methods simultaneously before the many neurotoxic triggers and cascades are initiated and become irreversible. This paper first discusses some triggers of neurotoxicity and neuroprotective mechanisms that block them, including hypothermia, alkalinization, and the administration of adenosine. It then examines how the simultaneous application of these techniques provides significantly greater neuroprotection than is provided by any technique alone. The paper also stresses the importance of determining whether the neuroprotection provided by these techniques can be further enhanced by combining them with additional techniques, such as the systemic administration of glucocorticoids. Finally, the paper stresses the absolute critical importance of applying these techniques within the "golden hour" following trauma, before the many neurotoxic events and cascades are manifest and before the neurotoxic cascades become irreversible.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 50 条
  • [1] Where do we stand on vascular calcification?
    Bostrom, Kristina I.
    VASCULAR PHARMACOLOGY, 2016, 84 : 8 - 14
  • [2] Nitric oxide synthase in plants: Where do we stand?
    Santolini, Jerome
    Andre, Francois
    Jeandroz, Sylvain
    Wendehenne, David
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2017, 63 : 30 - 38
  • [3] Rifampicin in periprosthetic joint infections: where do we stand and where are we headed?
    Wouthuyzen-Bakker, Marjan
    Scheper, Henk
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2023, 21 (07) : 695 - 701
  • [4] The Role of Angiogenesis in Haemophilic Arthropathy: Where Do We Stand and Where Are We Going?
    Agapidou, Alexandra
    Stavrakis, Thomas
    Vlachaki, Efthymia
    Anagnostis, Panagiotis
    Vakalopoulou, Sophia
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (02) : 88 - 93
  • [5] Artificial Blood and Nanotechnology: Where do We Stand?
    Hakami, Nora Y.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2024, 38 (03) : 1859 - 1873
  • [6] Marine Compounds and Cancer: Where Do We Stand?
    Dyshlovoy, Sergey A.
    Honecker, Friedemann
    MARINE DRUGS, 2015, 13 (09): : 5657 - 5665
  • [7] Carotid endarterectomy: where do we stand at present?
    Ritter, Jens C.
    Tyrrell, Mark R.
    CURRENT OPINION IN CARDIOLOGY, 2013, 28 (06) : 619 - 624
  • [8] NO synthesis and signaling in plants - where do we stand?
    Moreau, Magali
    Lindermayr, Christian
    Durner, Joerg
    Klessig, Daniel F.
    PHYSIOLOGIA PLANTARUM, 2010, 138 (04) : 372 - 383
  • [9] Design and engineering of artificial biosynthetic pathways-where do we stand and where do we go?
    Sokolova, Nika
    Peng, Bo
    Haslinger, Kristina
    FEBS LETTERS, 2023, 597 (23) : 2897 - 2907
  • [10] Systematic review seeking erythropoietin role for neuroprotection in neonates with hypoxic ischemic encephalopathy: presently where do we stand
    Garg, Bhawandeep
    Sharma, Deepak
    Bansal, Anju
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2018, 31 (23) : 3214 - 3224